10,000+ employees
Founded 1990
πΌ Consulting
π₯ Healthcare
π¦ Logistics
Consulting β’ Healthcare β’ Logistics
ICON plc is a global provider of clinical, consulting, and commercial services across various sectors in the healthcare and pharmaceutical industries. They offer a wide range of clinical solutions, including decentralised clinical trials, cardiac safety solutions, early clinical laboratories, and medical imaging. ICON also provides technology solutions that support drug development from early phases to post-marketing. Their therapeutic expertise spans cardiovascular, oncology, internal medicine, and more, with a strong focus on transformative therapies like cell and gene therapies and biosimilars. ICON is recognized as a leading Contract Research Organisation (CRO), regularly providing thought leadership and contributing to industry publications and events. Their services are tailored to optimize clinical trials, offer regulatory intelligence, and deliver real-world evidence through robust data analysis and patient-centric solutions.
π November 3
πΊπΈ United States β Remote
π΅ $195.8k - $244.8k / year
β° Full Time
π Senior
π΄ Lead
π Director
π» Ghost score 0%
Where this job comes from
Posted on ICON plc's careers page β, not through a job board
First seen by Remote Rocketship November 3
Still open on ICON plc's site. Checked 31 minutes ago.
10,000+ employees
Founded 1990
πΌ Consulting
π₯ Healthcare
π¦ Logistics
Consulting β’ Healthcare β’ Logistics
ICON plc is a global provider of clinical, consulting, and commercial services across various sectors in the healthcare and pharmaceutical industries. They offer a wide range of clinical solutions, including decentralised clinical trials, cardiac safety solutions, early clinical laboratories, and medical imaging. ICON also provides technology solutions that support drug development from early phases to post-marketing. Their therapeutic expertise spans cardiovascular, oncology, internal medicine, and more, with a strong focus on transformative therapies like cell and gene therapies and biosimilars. ICON is recognized as a leading Contract Research Organisation (CRO), regularly providing thought leadership and contributing to industry publications and events. Their services are tailored to optimize clinical trials, offer regulatory intelligence, and deliver real-world evidence through robust data analysis and patient-centric solutions.
β’ Lead strategic Cardiometabolic drug development design and deliver tailored, asset-focused solutions across liver diseases β’ Own end-to-end protocol development, including design, scientific review, and evaluation for Phase IβIV clinical trials β’ Advise senior client stakeholders on Cardiometabolic development strategy and data interpretation β’ Lead proposal development, study strategy, and bid defense activities β’ Build and maintain relationships with Cardiometabolic KOLs, advisory boards, and regulatory authorities β’ Develop Cardiometabolic-focused service offerings and support innovation and growth in liver disease drug development β’ Provide training, mentorship, and thought leadership to internal teams and external partners β’ Participate in portfolio reviews, governance discussions, and scientific oversight β’ Support operational teams with high-level scientific input, investigator meetings, and study discussions β’ Represent ICON at Cardiometabolic congresses and scientific forums
β’ Deep, recognized expertise in Cardiometabolic and liver disease drug development β’ Strong understanding of Cardiometabolic clinical trial design, biomarkers, endpoints, fibrosis staging, histologic and non-invasive markers, and evolving therapeutic landscapes β’ Proven ability to operate in a strategic, client-facing, consultative environment within pharmaceutical or clinical research settings β’ Experience engaging and influencing senior scientific and clinical stakeholders across industry and academia β’ Excellent communication and presentation skills, with ability to translate complex Cardiometabolic data into actionable development insights β’ Collaborative, global mindset with strong cross-functional leadership capability β’ MD required, ideally with specialization or substantial clinical/research experience in Cardiometabolic diseases β’ Legal right to work in the country where the role is based
β’ Competitive base salary and performance related incentives β’ Medical, dental, and vision coverage where applicable β’ Retirement and pension plans β’ Life assurance and disability coverage β’ Employee assistance programmes and wellbeing resources β’ Learning and development opportunities through structured training and career pathways β’ 20β40% domestic and international travel opportunity β’ Highly visible, impact-driven role shaping the future of Cardiometabolic drug development
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π November 3
Director overseeing investor, regulatory, and securitization reporting for Reprise Financial, a personal-loan fintech. Strengthening U.S. GAAP controls, portfolio reporting, and financing compliance.
π November 3
Associate Director leading integrated media and omnichannel strategies for pharmaceutical and life sciences clients. Advising on HCP and DTC engagement, investment, measurement, and optimization.
πΊπΈ United States β Remote
π΅ $100k - $115k / year
β° Full Time
π Senior
π Director
π¦ H1B Visa Sponsor
π November 3
Director leading StarTech.comβs global tech connectivity product development lifecycle. Driving NPI, regulatory compliance, quality, time-to-market, and cross-functional execution.
π November 3
Director shaping Dropboxβs pricing and packaging strategy across PLG, SLG, SaaS, and AI products. Leading monetization architecture, financial modeling, executive decisions, and a pricing team.
πΊπΈ United States β Remote
π΅ $202.6k - $342.7k / year
β° Full Time
π΄ Lead
π Director
π¦ H1B Visa Sponsor
π November 3
Sr. Director driving consultative sales and account expansion for OMNY Healthβs healthcare data and analytics platform. Building pharmaceutical, biotech, and medical device relationships.
πΊπΈ United States β Remote
π° Series B on 2022-11
β° Full Time
π‘ Mid-level
π Senior
π Director